190 related articles for article (PubMed ID: 28149927)
1. The Relationship of Industry Payments to Prescribing Behavior: A Study of Degarelix and Denosumab.
Bandari J; Turner RM; Jacobs BL; Canes D; Moinzadeh A; Davies BJ
Urol Pract; 2017 Jan; 4(1):14-20. PubMed ID: 28149927
[TBL] [Abstract][Full Text] [Related]
2. The lack of a relationship between physician payments from drug manufacturers and Medicare claims for abiraterone and enzalutamide.
Bandari J; Ayyash OM; Turner RM; Jacobs BL; Davies BJ
Cancer; 2017 Nov; 123(22):4356-4362. PubMed ID: 28749536
[TBL] [Abstract][Full Text] [Related]
3. Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data.
Sharma M; Vadhariya A; Johnson ML; Marcum ZA; Holmes HM
BMC Health Serv Res; 2018 Apr; 18(1):236. PubMed ID: 29609611
[TBL] [Abstract][Full Text] [Related]
4. Disclosure of industry payments to prescribers: industry payments might be a factor impacting generic drug prescribing.
Qian J; Hansen RA; Surry D; Howard J; Kiptanui Z; Harris I
Pharmacoepidemiol Drug Saf; 2017 Jul; 26(7):819-826. PubMed ID: 28485111
[TBL] [Abstract][Full Text] [Related]
5. Physician-Industry Interactions and Anti-Vascular Endothelial Growth Factor Use Among US Ophthalmologists.
Taylor SC; Huecker JB; Gordon MO; Vollman DE; Apte RS
JAMA Ophthalmol; 2016 Aug; 134(8):897-903. PubMed ID: 27356110
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical industry payments and delivery of non-recommended and low value cancer drugs: population based cohort study.
Mitchell AP; Dusetzina SB; Mishra Meza A; Trivedi NU; Bach PB; Winn AN
BMJ; 2023 Oct; 383():e075512. PubMed ID: 37879723
[TBL] [Abstract][Full Text] [Related]
7. Urology Payments from Industry in the Sunshine Act.
Bandari J; Turner RM; Jacobs BL; Davies BJ
Urol Pract; 2016 Sep; 3(5):332-337. PubMed ID: 27722187
[TBL] [Abstract][Full Text] [Related]
8. Association Between Payments by Pharmaceutical Manufacturers and Prescribing Behavior in Rheumatology.
Duarte-García A; Crowson CS; McCoy RG; Herrin J; Lam V; Putman MS; Ross JS; Matteson EL; Shah ND
Mayo Clin Proc; 2022 Feb; 97(2):250-260. PubMed ID: 35120693
[TBL] [Abstract][Full Text] [Related]
9. Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia.
Wood SF; Podrasky J; McMonagle MA; Raveendran J; Bysshe T; Hogenmiller A; Fugh-Berman A
PLoS One; 2017; 12(10):e0186060. PubMed ID: 29069085
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Psychiatrist-Industry Financial Relationship: Insight from the Open Payment Data of Centers for Medicare and Medicaid Services.
Rhee TG; Wilkinson ST
Adm Policy Ment Health; 2020 Jul; 47(4):526-530. PubMed ID: 31916072
[TBL] [Abstract][Full Text] [Related]
11. Variations in Medicare Reimbursement in Radiation Oncology: An Analysis of the Medicare Provider Utilization and Payment Data Set.
Vu CC; Lanni TB; Robertson JM
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1000-5. PubMed ID: 27026306
[TBL] [Abstract][Full Text] [Related]
12. The Sunshine Act and Surgeons: A Nation-Wide Analysis of Industry Payments to Physicians.
Garstka ME; Monlezun D; DuCoin C; Killackey M; Kandil E
J Surg Res; 2019 Jan; 233():41-49. PubMed ID: 30502279
[TBL] [Abstract][Full Text] [Related]
13. Industry ties in otolaryngology: initial insights from the physician payment sunshine act.
Rathi VK; Samuel AM; Mehra S
Otolaryngol Head Neck Surg; 2015 Jun; 152(6):993-9. PubMed ID: 25779469
[TBL] [Abstract][Full Text] [Related]
14. Receiving Industry Payments is Associated with Prescribing Habits of Tadalafil.
Chua KJ; Li G; Stahl PJ; Hyams ES
Urol Pract; 2019 Sep; 6(5):282-288. PubMed ID: 37317353
[TBL] [Abstract][Full Text] [Related]
15. Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs.
Perlis RH; Perlis CS
PLoS One; 2016; 11(5):e0155474. PubMed ID: 27183221
[TBL] [Abstract][Full Text] [Related]
16. Exploring the Industry-Dermatologist Financial Relationship: Insight From the Open Payment Data.
Feng H; Wu P; Leger M
JAMA Dermatol; 2016 Dec; 152(12):1307-1313. PubMed ID: 27706478
[TBL] [Abstract][Full Text] [Related]
17. Industry payments to female pelvic medicine and reconstructive surgeons: an analysis of Sunshine Act open payments from 2014-2017.
Teplitsky S; Perez T; Leong JY; Xie K; Murphy A; Shenot PJ
Int Urogynecol J; 2020 Apr; 31(4):799-807. PubMed ID: 31673796
[TBL] [Abstract][Full Text] [Related]
18. Deciphering the Sunshine Act: Transparency Regulation and Financial Conflicts in Health Care.
Saver RS
Am J Law Med; 2017 Nov; 43(4):303-343. PubMed ID: 29452562
[TBL] [Abstract][Full Text] [Related]
19. Physician characteristics, industry transfers, and pharmaceutical prescribing: Empirical evidence from medicare and the physician payment sunshine act.
Brunt CS
Health Serv Res; 2019 Jun; 54(3):636-649. PubMed ID: 30273976
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.
DeJong C; Aguilar T; Tseng CW; Lin GA; Boscardin WJ; Dudley RA
JAMA Intern Med; 2016 Aug; 176(8):1114-1122. PubMed ID: 27322350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
